ABBOTT LABORATORIES — Director's Dealing 2005

Feb 23, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2005-02-18

Reporting Person: NEMMERS JOSEPH M (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-02-18	Common shares without par value	A	9300	$46.34	Acquired	62530	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2005-02-18	Option (right to buy)	$46.34	A	63800	Acquired	2015-02-17	common shares (63800)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	10642	Indirect
Common shares without par value	340	Indirect
Common shares without par value	340	Indirect
Common shares without par value	279	Indirect
Common shares without par value	285	Indirect

Footnotes

F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 17, 2005.

F3: Reporting person disclaims beneficial ownership of all securities held by his sons.

F4: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.

F5: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 21,267 on 2/18/06, 21,267 on 2/18/07, and 21,266 on 2/18/08.